Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology

Volumn 38, Issue 2 I, 1998, Pages 207-220

  Vonderheid, E C ^a   Zhang, Q ^a   Lessin, S R ^a   Polansky, M ^a   Abrams, J T ^a   Bigler, R D ^a   Wasik, M A ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHLORMETHINE; INTERLEUKIN 2 RECEPTOR; METHOTREXATE;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PUVA; T CELL LYMPHOMA; TREATMENT OUTCOME;

EID: 0031885856     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70597-3     Document Type: Article

References (28)

1. M Lutzner R Edelson P Schein I Green C Kirkpatrick A Ahmed Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders Ann Intern Med 83 1975 534 552
2. EA Abel GS Wood RT Hoppe Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment CA Cancer J Clin 43 1993 93 115
3. E Dmitrovsky MJ Matthews PA Bunn GP Schechter RW Makuch CF Winkler Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis J Clin Oncol 5 1987 208 215
4. JP Greer KE Salhany JB Cousar JP Fields LE King SE Graber Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process Hematol Oncol 8 1990 215 227
5. R Edelson C Berger F Gasparro B Jegasothy P Heald B Wintroub Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy N Engl J Med 316 1987 297 303
6. PW Heald MI Perez I Christensen N Dobbs G McKiernan R Edelson Photopheresis therapy of cutaneous T-cell lymphoma: the Yale–New Haven Hospital experience Yale J Biol Med 62 1989 629 638
7. S Armus B Keyes C Cahill C Berger D Crater D Scarborough Photopheresis for the treatment of cutaneous T cell lymphoma J Am Acad Dermatol 23 1990 898 902
8. HK Koh BE Davis T Meola HW Lim Extracorporeal photopheresis for the treatment of 34 patients with cutaneous T cell lymphoma (CTCL) [abstract] J Invest Dermatol 102 1994 567
9. M Duvic JP Hester NA Lemak Photopheresis therapy for cutaneous T-cell lymphoma J Am Acad Dermatol 35 1996 573 579
10. JA Zic GP Stricklin JP Greer MC Kinney Y Shyr DC Wilson Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy J Am Acad Dermatol 35 1996 935 945
11. SL Gottlieb JT Wolfe FE Fox BJ DeNardo WH Macey PG Bromley Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution J Am Acad Dermatol 35 1996 946 957
12. P Heald A Rook M Perez B Wintroub R Knobler B Jegasothy Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy J Am Acad Dermatol 27 1992 427 433
13. AH Rook MB Prystowsky M Cassin M Boufal SR Lessin Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy: clinical, molecular, and immunologic observations Arch Dermatol 127 1991 1535 1540
14. EC Vonderheid RD Bigler AS Greenberg SJ Neukum B Micaily Extracorporeal photopheresis and recombinant interferon alfa in Sézary syndrome: use of dual marker labeling to monitor therapeutic response Am J Clin Oncol 17 1994 255 263
15. LA Rubin DL Nelson The soluble interleukin-2 receptor: biology, function, and clinical application Ann Intern Med 113 1990 619 627
16. C Zachariae CS Larsen K Kaltoft B Deleuran CG Larsen K Thestrup-Pedersen Soluble IL2 receptor serum levels and epidermal cytokines in mycosis fungoides and related disorders Acta Derm Venereol 71 1991 465 470
17. R Dummer F Nestle J Wiede E Schäfer J Röger JC Becker Coincidence of increased soluble interleukin-2 receptors, diminished natural killer cell activity and progressive disease in cutaneous T-cell lymphomas Eur J Dermatol 1 1991 135 138
18. R-M Szeimies F Rueff P Kaudewitz Soluble interleukin-2 receptor serum levels in mycosis fungoides: correlation with clinical stage Cancer 70 1992 2338 2341
19. C Neish M Charley B Jegasothy M Tharp JS Deng Proliferation cell nuclear antigen and soluble interleukin 2 receptor levels in cutaneous T cell lymphoma: correlation with advanced clinical diseases J Dermatol Sci 8 1994 11 17
20. MA Wasik EC Vonderheid RD Bigler R Marti SL Lessin M Polansky Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma: clinical and prognostic implications Arch Dermatol 132 1996 42 47
21. MG Bernengo MT Fierro M Novelli F Lisa A Appino Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application Br J Dermatol 128 1993 124 129
22. BD Goldman O Se-Kyung BE Davis ME Kadin BJ Poiesz HK Koh Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment Arch Dermatol 129 1993 1166 1170
23. RM Marti T Estrach JC Reverter JM Mascaro Prognostic clinicopathologic factors in cutaneous T-cell lymphoma Arch Dermatol 127 1991 1511 1516
24. EC Vonderheid EL Sobel PC Nowell JB Finan MK Helfrich DS Whipple Diagnostic and prognostic significance of Sézary cells in peripheral blood smears from patients with cutaneous T-cell lymphoma Blood 66 1995 358 366
25. JM Weinberg C Jaworsky BM Benoit B Telegan AH Rook SL Lessin The clonal nature of circulating Sézary cells Blood 86 1995 4257 4262
26. RD Bigler P Crilley B Micaily LW Brady D Topolsky S Bulova Autologous bone marrow transplantation for advanced stage mycosis fungoides Bone Marrow Transplant 7 1991 133 137
27. TA Waldmann WC Greene PS Sarin C Saxinger DW Blayney WA Blattner Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac monoclonal antibody identifying the human receptor for T cell growth factor J Clin Invest 73 1984 1711 1718
28. PA Bunn Jr R Edelson SS Ford SE Shackney Patterns of cell proliferation and cell migration in the Sézary syndrome Blood 57 1981 452 463